PRINCETON, N.J. - Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN), a clinical-stage biotechnology company with a market capitalization of $4.69 million, announced its intention to further ...
PRINCETON - Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN), a clinical-stage biotechnology company specializing in immunotherapy treatments with a current market capitalization of $4.69 ...
PRINCETON, N.J. - Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN), a clinical-stage biotechnology company with a market capitalization of $4.69 million, announced its intention to further develop ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback